Stock comparison
ResMed
UnitedHealth
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
RMD
ResMed
Market cap
$30.18B
Sector
Healthcare
UNH
UnitedHealth
Market cap
$352.79B
Sector
Healthcare
Overall winner
ResMed RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | RMD | UNH | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 44D | RMD |
| Benjamin Graham | 75B | 67B | RMD |
| Philip Fisher | 75B | 29F | RMD |
| Peter Lynch | 58C | 23F | RMD |
| Joel Greenblatt | 47D | 37D | RMD |
| Charlie Munger | 69B | 36D | RMD |
| Terry Smith | 73B | 39D | RMD |
Side-by-side metrics
| Metric | RMD | UNH |
|---|---|---|
| Market cap | $30.18B | $352.79B |
| P/E (TTM) | 19.6x | 29.0x |
| EV/EBIT | 17.1x | 21.0x |
| ROIC (TTM) | 19.63% | 8.09% |
| Gross margin | 61.69% | 18.8% |
| Net margin | 27.44% | 2.68% |
| Revenue CAGR 5y | 12.64% | 11.69% |
| EPS CAGR 5y | 30.73% | -7.83% |
| Debt / Equity | 0.1x | 0.7x |
| Dividend yield | 1.14% | 2.3% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
RMD leads on
- EPS CAGR 5y30.73%vs -7.83%+125%
- Net margin27.44%vs 2.68%+90%
- Debt / Equity0.1xvs 0.7x+83%
- Gross margin61.69%vs 18.8%+70%
UNH leads on
- Market cap$352.79Bvs $30.18B+91%
- Dividend yield2.3%vs 1.14%+50%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.